Dr. Daniela Kremer
Dr. Daniela Kremer studied biology at the University of Bonn and Heinrich-Heine-University Düsseldorf, focusing on immunology and epigenetics. Following her postdoctoral research in the field of cell biology and anatomy at the University of Duisburg-Essen and Julius-Maximilians-University Würzburg, she worked as a quality manager in a cord blood bank. She then continued her career at LTS Lohmann-Therapiesysteme, where she spent 8 years as a quality manager (GMP, GCP, ISO 13485) and head of analytical development and quality control (Ph.Eur., GMP).
In April 2022, she joined Miltenyi Biotec as Manager/Director Quality Control Cell Therapy (GMP ATMP). Her primary focus is on achieving a balance between research and development and quality regulations.